Condition: Acute Ischemic Stroke AIS · Sponsor: S&Ebio Co. Ltd.
This is a multicenter open-label, single-arm, dose escalation phase I clinical trial to evaluate the safety and tolerability of SNE-101 in patients with acute ischemic stroke
This description comes directly from the study's public registry record.
Oh Young Bang, MD, Ph.D · +82-2-2054-8128 · ohyoung.bang@snebio.com
SeungWoo Yeon, Ph.D · +82-2-2054-8109 · swyeon@snebio.com
Always discuss trial participation with your own doctor first.
| Ajou University Hospital | Suwon, Gyeonggi-do, South Korea | Recruiting |
| Samsung Medical Center | Seoul, South Korea | Recruiting |
| Ewha Womans University Seoul Hospital | Seoul, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06995625